DIABLO INFERNO
Natural health product licensed in Canada
- Licence holder
- Advanced Nutraceutical Sciences Inc.
- NPN or DIN-HM
- 80063678
- Status
- Active licence
- Licence date
- 28 August 2015
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 1,3,7-triméthylxanthine Source : Caféine | 100 milligramme | Not calculated |
| L-Carnitine Source : L-tartrate de carnitine | 500 milligramme | Not calculated |
Non-medicinal ingredients
Hypromellose, Dioxyde de titane, Silice
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Sexe masculin | minimum: 18 years | 1 Capsule | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
| Sexe féminin | minimum: 18 years | 1 Capsule | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Caffeine helps (temporarily) to relieve fatigue, to promote endurance, and to enhance motor performance.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy is known to occur, in which case, discontinue use.
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a healthcare practitioner prior to use,. If you have a liver disease, a kidney disease, or a seizure disorder, consult a healthcare practitioner prior to use. Consult a health care practitioner prior to use if you are taking lithium. Consult a health care practitioner prior to use if you have high blood pressure, glaucoma, and/or detrusor instability (overactive bladder syndrome). Consumption with natural health products (e.g. bitter orange extract, synephrine, octopamine, ephedra) or other drugs (e.g. ephedrine) which increase blood pressure is not recommended. Consumption with other caffeine-containing products (e.g. medications, coffee, tea, colas, cocoa, guarana, maté) is not recommended. This product is not intended as a substitute for sleep. Consult a health care practitioner if you are of childbearing age, pregnant or breastfeeding. Ensure to drink enough fluid before, during and after exercise.
Source
Official Health Canada record, licence 80063678
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.